Short- and long-term amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct

Noboru Yamashita1, Toshihiko Kaku, Tomoko Uchino

  • 1Department of Cardiovascular Science and Internal Medicine, Oita University School of Medicine, 1-1 Idaigaoka, Hasama, Yufu, Oita 879-5593, Japan.

Molecular Pharmacology
|January 31, 2006
PubMed

Insights

Amiodarone affects T-type calcium channels (ICa.T) through distinct short- and long-term mechanisms. Short-term amiodarone application blocks ICa.T, while long-term exposure reduces channel density and alters gating properties, impacting atrial arrhythmias.

Area of Science:

  • Cardiovascular Pharmacology
  • Ion Channel Physiology

Background:

  • Low-voltage-activated T-type Ca2+ channels (ICa.T) are implicated in atrial arrhythmias.
  • The specific pharmacological actions of amiodarone on T-type Ca2+ channels are not well understood.

Purpose of the Study:

  • To investigate the short- and long-term effects of amiodarone on the human cardiac T-type Ca2+ channel (Cav3.2).

Main Methods:

  • Stable transfection of human Cav3.2 into HEK cells (HEK-Cav3.2).
  • Patch-clamp recordings to assess amiodarone's effects on ICa.T.
  • Short-term (acute bath application) and long-term (72-hour incubation) amiodarone treatments.

Main Results:

  • Short-term amiodarone acutely blocked ICa.T in a dose- and voltage-dependent manner, shifting activation and inactivation curves hyperpolarizing.
  • Long-term (72h) amiodarone incubation significantly decreased ICa.T density by 31.7% and shifted activation/inactivation curves depolarizing.
  • Long-term amiodarone treatment also delayed current inactivation and maintained short-term inhibitory effects on the modified channel.

Conclusions:

  • Amiodarone exerts distinct short- and long-term inhibitory mechanisms on T-type Ca2+ channels (Cav3.2).
  • These dual actions suggest complex modulation of cardiac electrophysiology by amiodarone, potentially influencing atrial arrhythmias.

Related Concept Videos

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Depolarizing Blockers: Mechanism of Action01:28

Depolarizing Blockers: Mechanism of Action

Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...